In the U.K., two instances of evidently inept work by radiologists are inadvertently spotlighting the value of subspecialized image interpretation in socially sensitive patient cases.

Dense breast experts Wendie Berg, MD, and JoAnn Pushkin, executive director of DenseBreast-info Inc., explain the current status of breast density patient inform laws, reimbursement and new technologies to aid cancer detection. 

An AI startup in the neuro-oncology space has received the government’s go-ahead to market software for analyzing certain fast-growing brain tumors on MRI.

Should patients read their radiology reports ahead of the doctor who ordered the exam? That’s not a new question. It was supposed to have been settled in the affirmative by the 21st Century Cures Act.

The criminal saga of the X-ray business owner who got caught fleecing CMS of $2 million—while grabbing for another $1.7 million or so—has reached its epilogue.

The Federal Aviation Administration assesses pilots for five “hazardous attitudes” that may forewarn of risky behaviors in the air. Therapeutic radiology researchers have adapted the FAA scale for radiation oncologists making treatment decisions.

More than 120 medical societies have joined the AMA in a letter urging congressional leaders to enact long-term solutions to the systemic problems in the Medicare physician payment system and to address cuts that are going into effect in 2023.

The Sept. 21 announcement states that Gadopiclenol Injection—a highly stable macrocyclic gadolinium-based contrast agent—is approved for use in adult and pediatric patients aged 2 years and older during MRI exams.